Jiangsu Changyou Environmental Protection Technology
301557
Hefei conver Holding
603409
LIERDA
832149
4
SHENGNAN TECHNOLOGY
837006
5
CHK
831167
US Stock MarketDetailed Quotes
IBRX ImmunityBio
- 3.020
- +0.170+5.96%
Close Mar 4 16:00 ET
- 3.050
- +0.030+0.99%
Post 19:22 ET
2.58BMarket Cap-4.87P/E (TTM)
3.170High2.700Low8.91MVolume2.800Open2.850Pre Close26.27MTurnover10.92%Turnover RatioLossP/E (Static)853.44MShares10.53052wk High-5.27P/B246.36MFloat Cap2.28052wk Low--Dividend TTM81.58MShs Float45.420Historical High--Div YieldTTM16.49%Amplitude0.930Historical Low2.949Avg Price1Lot Size
ImmunityBio Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.67%-391.24M | 26.12%-85.13M | -12.95%-98.78M | -25.79%-100.35M | -26.89%-106.98M | -8.67%-366.76M | -27.00%-115.22M | -8.50%-87.45M | 12.58%-79.77M | -12.52%-84.31M |
| Net income from continuing operations | 29.15%-413.65M | 74.65%-59.18M | 10.34%-85.75M | 2.63%-134.58M | -15.05%-134.13M | -39.91%-583.85M | -115.47%-233.41M | 13.96%-95.64M | -45.74%-138.21M | -13.19%-116.58M |
| Operating gains losses | -170.24%-33.43M | -103.94%-3.13M | -130.90%-32.94M | -118.90%-1.89M | 116.43%4.53M | 453.64%47.6M | --79.4M | ---14.27M | --10.02M | ---27.55M |
| Depreciation and amortization | -5.18%17.55M | -9.93%4.15M | -2.16%4.44M | -5.89%4.41M | -2.69%4.56M | 1.38%18.51M | -11.75%4.61M | 0.82%4.54M | 5.36%4.68M | 14.45%4.68M |
| Other non cash items | -74.73%24.13M | -155.43%-25.28M | 82.26%18.12M | -29.49%16.38M | -10.89%14.91M | 170.46%95.5M | 162.26%45.6M | 24.71%9.94M | 454.56%23.23M | 190.45%16.73M |
| Change In working capital | -588.36%-19.42M | 57.89%-10.84M | -43.51%-10.05M | -40.80%5.36M | -114.07%-3.89M | 149.71%3.98M | -290.73%-25.75M | -194.89%-7M | 149.23%9.06M | 187.87%27.67M |
| -Change in receivables | ---2.36M | --1.82M | ---3.14M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in inventory | ---8.27M | ---6.31M | ---147K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in prepaid assets | -71.42%1.7M | 138.03%1.33M | -56.33%-2.78M | -2.39%1.51M | -83.14%1.63M | 135.98%5.96M | -64.01%-3.51M | -3,390.74%-1.78M | 110.88%1.55M | 4,544.50%9.69M |
| -Change in payables and accrued expense | -2,294.84%-4.68M | 76.21%-5.33M | 38.57%-2.7M | 2.78%7.95M | -123.90%-4.6M | -98.24%213K | -725.09%-22.39M | -157.16%-4.39M | 270.08%7.74M | 64.80%19.26M |
| -Change in other current assets | -157.92%-1.11M | -295.83%-1.03M | -175.44%-255K | -93.48%49K | -55.25%132K | -4.25%1.91M | 477.14%528K | -76.51%338K | 25.75%752K | 192.08%295K |
| -Change in other current liabilities | -83.78%-5.47M | -179.96%-1.54M | -36.82%-1.52M | -901.05%-1.52M | 40.57%-898K | 31.05%-2.98M | 72.73%-549K | -889.29%-1.11M | 110.24%190K | -345.72%-1.51M |
| -Change in other working capital | 167.58%763K | 31.18%223K | 822.39%484K | 118.27%214K | -159.02%-158K | 7.84%-1.13M | -58.94%170K | 96.01%-67K | -170.58%-1.17M | 96.23%-61K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -6.67%-391.24M | 26.14%-85.14M | -13.00%-98.76M | -25.79%-100.35M | -26.89%-106.98M | -8.67%-366.76M | -27.05%-115.27M | -8.44%-87.4M | 12.58%-79.77M | -12.52%-84.31M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 59.81%-12.25M | 337.26%9.83M | 516.05%65.03M | -498.44%-51.49M | -319.87%-35.62M | -211.62%-30.47M | 111.90%2.25M | -1,238.27%-15.63M | -107.37%-8.6M | 87.76%-8.48M |
| Net PPE purchase and sale | 77.48%-6.89M | 73.46%-2.11M | 50.80%-2.79M | 91.51%-724K | 85.04%-1.26M | 60.87%-30.58M | 57.98%-7.96M | 64.39%-5.68M | 46.54%-8.53M | 69.18%-8.43M |
| Net intangibles purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | -3,922.81%-4.36M | 17.06%11.95M | 791.28%68.82M | -64,984.62%-50.77M | -61,258.93%-34.36M | -99.91%114K | 27,478.38%10.2M | -167.42%-9.96M | -100.06%-78K | 99.72%-56K |
| Net other investing changes | ---1M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 59.81%-12.25M | 337.26%9.83M | 516.05%65.03M | -498.44%-51.49M | -319.87%-35.62M | -211.62%-30.47M | 111.90%2.25M | -1,238.27%-15.63M | -107.37%-8.6M | 87.76%-8.48M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -49.56%281.63M | -46.68%106.93M | -93.44%15.58M | 242.98%148.89M | -86.70%10.23M | 139.00%558.34M | 82.41%200.54M | 91.56%237.5M | 289,513.33%43.41M | 25,901.34%76.89M |
| Net issuance payments of debt | -100.02%-64K | --0 | -100.01%-22K | -100.07%-21K | -100.07%-21K | 48.58%258.62M | -100.04%-20K | 60.04%198.98M | --29.83M | --29.83M |
| Net common stock issuance | 1.14%111.36M | 1,051.47%107.73M | --0 | -73.16%3.63M | --0 | 82.21%110.1M | -84.52%9.36M | --39.95M | --13.51M | --47.29M |
| Cash dividends paid | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Proceeds from stock option exercised by employees | 2,430.30%73.38M | 48.56%-803K | 1,189.66%15.6M | 15,867.38%44.46M | 11,103.17%14.12M | -481.00%-3.15M | -612.79%-1.56M | -14,220.00%-1.43M | 27.13%-282K | 70.27%126K |
| Net other financing activities | -49.70%96.96M | --0 | --0 | --100.82M | -983.19%-3.87M | 56,962.54%192.76M | ---- | ---- | ---- | 4.03%-357K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -49.56%281.63M | -46.68%106.93M | -93.44%15.58M | 242.98%148.89M | -86.70%10.23M | 139.00%558.34M | 82.41%200.54M | 91.56%237.5M | 289,513.33%43.41M | 25,901.34%76.89M |
| Net cash flow | ||||||||||
| Beginning cash position | 153.21%265.79M | -37.02%112.3M | 197.60%130.44M | 50.18%133.37M | 153.21%265.79M | -42.10%104.97M | 70.64%178.3M | -29.56%43.83M | 142.88%88.81M | -42.10%104.97M |
| Current changes in cash | -175.63%-121.85M | -63.87%31.62M | -113.50%-18.15M | 93.45%-2.94M | -732.26%-132.38M | 310.33%161.11M | 27,334.80%87.52M | 218.51%134.47M | -276.99%-44.97M | 89.00%-15.91M |
| Effect of exchange rate changes | 92.12%-23K | 74.07%-7K | 1,200.00%11K | 220.00%12K | 84.65%-39K | -202.82%-292K | -116.77%-27K | -102.33%-1K | -103.92%-10K | -45.14%-254K |
| End cash Position | -45.85%143.91M | -45.85%143.91M | -37.02%112.3M | 197.60%130.44M | 50.18%133.37M | 153.21%265.79M | 153.21%265.79M | 70.64%178.3M | -29.56%43.83M | 142.88%88.81M |
| Free cash flow | -0.20%-398.12M | 29.19%-87.26M | -9.11%-101.56M | -14.46%-101.07M | -16.72%-108.24M | 9.05%-397.34M | -12.37%-123.23M | 3.58%-93.08M | 17.63%-88.3M | 24.91%-92.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
As China's 'two sessions' approach: How will Chinese stocks perform?
🎙️Discussion 1. With China's 'two sessions' approaching, do you focus more on policy dynamics or capital flows? 2. Which industry sectors d
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites